Astera Labs (NASDAQ:ALAB) Now Covered by JPMorgan Chase & Co.

JPMorgan Chase & Co. initiated coverage on shares of Astera Labs (NASDAQ:ALABFree Report) in a research note published on Monday morning, Marketbeat reports. The firm issued an overweight rating and a $85.00 price objective on the stock.

Other analysts also recently issued reports about the stock. Northland Securities began coverage on shares of Astera Labs in a research report on Monday, March 25th. They issued an outperform rating and a $85.00 target price on the stock. Needham & Company LLC began coverage on shares of Astera Labs in a research report on Monday. They issued a buy rating and a $85.00 target price on the stock. Roth Mkm began coverage on shares of Astera Labs in a research report on Monday. They issued a buy rating and a $85.00 target price on the stock. Stifel Nicolaus began coverage on shares of Astera Labs in a research report on Monday. They issued a buy rating and a $81.00 target price on the stock. Finally, Barclays began coverage on shares of Astera Labs in a research report on Monday. They issued an overweight rating and a $85.00 target price on the stock. Eleven analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has a consensus rating of Buy and an average target price of $86.09.

Read Our Latest Stock Report on Astera Labs

Astera Labs Stock Down 3.1 %

NASDAQ:ALAB opened at $70.92 on Monday. Astera Labs has a 1-year low of $50.61 and a 1-year high of $95.21.

Insider Activity at Astera Labs

In related news, Director Jack R. Lazar purchased 10,000 shares of the company’s stock in a transaction dated Friday, March 22nd. The shares were purchased at an average price of $36.00 per share, with a total value of $360,000.00. Following the acquisition, the director now directly owns 165,000 shares in the company, valued at approximately $5,940,000. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

Institutional Trading of Astera Labs

A hedge fund recently bought a new stake in Astera Labs stock. Allspring Global Investments Holdings LLC purchased a new stake in shares of Astera Labs, Inc. (NASDAQ:ALABFree Report) during the first quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 251,596 shares of the company’s stock, valued at approximately $18,666,000. Allspring Global Investments Holdings LLC owned about 0.16% of Astera Labs as of its most recent SEC filing.

About Astera Labs

(Get Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Recommended Stories

Analyst Recommendations for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.